A study to reveal the patient characteristics and treatment patterns of stage III non-small-cell lung cancer patients

Trial Identifier: D133HR00004
Sponsor: AstraZeneca
NCTID:: NCT03725475
Start Date: November 2018
Primary Completion Date: September 2019
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina Buenos Aires, Argentina
Argentina Rosario, Argentina
Chile Santiago de Chile, Chile
Colombia Cali, Colombia
Colombia Cordoba, Colombia
Colombia Medellin, Colombia
Dominican Republic Santo Domingo, Dominican Republic
India Anand, India
India Bangalore, India
India Calicut, India
India Chennai, India
India Mohali, India
India Mumbai, India
India Nashik, India
India New Delhi, India
India Odissa, India
India Srinagar, India
India West Bengal, India
Mexico Guadalajara, Mexico
Mexico Mexico City, Mexico
Mexico Toluca, Mexico
Peru Lima, Peru
Taiwan Kaohsiung, Taiwan
Taiwan Taichung, Taiwan
Taiwan Tainan, Taiwan
Taiwan Taipei, Taiwan
Taiwan TaoYuan, Taiwan
Thailand Bangkoknoi, Thailand
Thailand Dusit, Thailand
Thailand Pathumwan, Thailand
Thailand Ratchathewi, Thailand
Uruguay Montevideo, Uruguay